For example, TBX3 had high TSG scores in ER+ (TSG=58%, 6.0% of ER+ samples with coding mutations) and ER− (22%, 2.2%) tumours, and was also significantly mutated relative to the background mutation rate in the TCGA data set7. The gene discussed is TBX3; the disease is neoplasm.